Potent beta-adrenergic antagonist possessing chemically reactive group.
D000318:Adrenergic beta-Agonists; D000526:Alprenolol / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D000081005:Cyclohexane Monoterpenes; D004082:Dihydroalprenolol / Q000378:metabolism; D004910:Erythrocyte Membrane / Q000378:metabolism; D007700:Kinetics; D011898:Ranidae; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000378:metabolism*
D000318:Adrenergic beta-Agonists; D000081005:Cyclohexane Monoterpenes; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; C028413:dihydroalprenolol receptor; D004082:Dihydroalprenolol; C028414:1-(2-allylphenoxy)-3-((8-amino-4-menthane-1-yl)amino)-2-propanol; C028415:1-(2-allylphenoxy)-3-((1-amino-4-menthane-8-yl)amino)-2-propanol; C028417:1-(2-allylphenoxy)-3-((8-bromoacetylamino-4-menthane-1-yl)amino)-1-propanol; C028416:1-(2-allylphenoxy)-3-((1-bromoacetylamino-4-menthane-8-yl)amino)-2-propanol; D000526:Alprenolol